BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36419107)

  • 41. Molecular Mechanism of Integrin αvβ6 in Liver Metastasis of Colon Cancer Based on SDF-1/CXCR4.
    Shi J; Fan L; Li B; Pan H
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):88-95. PubMed ID: 35818267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the combined expression of chemokine SDF-1α and its receptor CXCR4 as a prognostic marker for gastric cancer.
    Lee HJ; Huang SM; Kim HY; Oh YS; Hwang JY; Liang ZL; Ki Min J; Yun HJ; Sul JY; Kim S; Jo DY; Kim JM
    Exp Ther Med; 2011 May; 2(3):499-504. PubMed ID: 22977531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
    Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
    Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
    Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathological significance of chemokine receptor CXCR4 expression in papillary thyroid carcinoma: a meta-analysis.
    Wu Z; Cao Y; Jiang X; Li M; Wang G; Yang Y; Lu K
    Minerva Endocrinol; 2020 Mar; 45(1):43-48. PubMed ID: 29424203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma.
    Yang YC; Lee ZY; Wu CC; Chen TC; Chang CL; Chen CP
    Int J Gynecol Cancer; 2007; 17(3):676-86. PubMed ID: 17504381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune profiling identifies CD8
    Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX
    Front Immunol; 2022; 13():894919. PubMed ID: 36420264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
    Chen Z; Teo AE; McCarty N
    Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
    D'Alterio C; Buoncervello M; Ieranò C; Napolitano M; Portella L; Rea G; Barbieri A; Luciano A; Scognamiglio G; Tatangelo F; Anniciello AM; Monaco M; Cavalcanti E; Maiolino P; Romagnoli G; Arra C; Botti G; Gabriele L; Scala S
    J Exp Clin Cancer Res; 2019 Oct; 38(1):432. PubMed ID: 31661001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.
    De Falco V; Guarino V; Avilla E; Castellone MD; Salerno P; Salvatore G; Faviana P; Basolo F; Santoro M; Melillo RM
    Cancer Res; 2007 Dec; 67(24):11821-9. PubMed ID: 18089812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SDF-1alpha is a potent inducer of HIV-1-Specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads.
    Meditz AL; Schlichtemeier R; Folkvord JM; Givens M; Lesh KC; Ray MG; McCarter MD; Connick E
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):977-85. PubMed ID: 18671480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
    De-Colle C; Menegakis A; Mönnich D; Welz S; Boeke S; Sipos B; Fend F; Mauz PS; Tinhofer I; Budach V; Abu Jawad J; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Belka C; Ganswindt U; Pigorsch S; Combs SE; Lohaus F; Linge A; Krause M; Baumann M; Zips D;
    Radiother Oncol; 2018 Jan; 126(1):125-131. PubMed ID: 29061496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulated stromal cell-derived factor 1 (SDF-1) expression and its interaction with CXCR4 contribute to the pathogenesis of severe pterygia.
    Kim KW; Park SH; Lee SH; Kim JC
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7198-206. PubMed ID: 24114538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.
    Walther F; Berther JL; Lalos A; Ramser M; Eichelberger S; Mechera R; Soysal S; Muenst S; Posabella A; Güth U; Stadlmann S; Terracciano L; Droeser RA; Zeindler J; Singer G
    BMC Cancer; 2022 Apr; 22(1):376. PubMed ID: 35397601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
    Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study on CXCR4/SDF-1alpha axis in lymph node metastasis of cervical squamous cell carcinoma.
    Zhang JP; Lu WG; Ye F; Chen HZ; Zhou CY; Xie X
    Int J Gynecol Cancer; 2007; 17(2):478-83. PubMed ID: 17362322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
    Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
    Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.